NK

NantKwest (NK)

NantKwest Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NK

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2020/05/19	21:00	Business Wire	Be The Match BioTherapies & NantKwest Announce Collaboration to Accelerate Development of Cell Therapy to Prevent COVID-19 De...	NASDAQ:NK	NantKwest Inc
2020/05/18	21:30	Business Wire	NantKwest Announces FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-...	NASDAQ:NK	NantKwest Inc
2020/05/15	05:25	Business Wire	NantKwest and ImmunityBio to Initiate a Phase 2 Study of Immunotherapy for Metastatic Pancreatic Cancer	NASDAQ:NK	NantKwest Inc
2020/05/12	05:09	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NK	NantKwest Inc
2020/04/30	05:15	Business Wire	NantKwest and ImmunityBio to Present at the Bank of America Merrill Lynch Global Healthcare Conference	NASDAQ:NK	NantKwest Inc
2020/04/25	05:03	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:NK	NantKwest Inc
2020/04/14	21:30	Business Wire	NantKwest & ImmunityBio Announce Therapeutics & Vaccines for Combatting COVID-19; Clinical Trials Anticipated to Begin This Q...	NASDAQ:NK	NantKwest Inc
2020/03/26	05:11	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:NK	NantKwest Inc
2020/03/25	06:48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NK	NantKwest Inc
2020/03/19	21:00	Business Wire	NantKwest Doses First Patient in Phase 2 Single-Arm Trial of Metastatic Merkel Cell Carcinoma Therapy With Off-the-Shelf CD16...	NASDAQ:NK	NantKwest Inc
2020/01/16	22:00	Business Wire	Progress Report on Cancer Breakthroughs 2020 Project Presented by Dr. Soon-Shiong at J.P. Morgan Healthcare Conference	NASDAQ:NK	NantKwest Inc
2019/12/16	21:00	Business Wire	NantKwest & ImmunityBio Present Results of Landmark Trial of First-in-Human Natural Killer Cell Combination Immunotherapy Wit...	NASDAQ:NK	NantKwest Inc
2019/12/13	08:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NK	NantKwest Inc
2019/12/03	06:05	Business Wire	NantKwest Announces Phase 1 Results for First-in-Human PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) in Patients w...	NASDAQ:NK	NantKwest Inc
2019/11/27	22:00	Business Wire	NantKwest Hosting Key Opinion Leader Meeting on Novel Immunotherapeutic Approaches to Address the Unmet Medical Needs of Pati...	NASDAQ:NK	NantKwest Inc
2019/11/08	06:15	Business Wire	NantKwest Announces Presentation of Positive Phase 2 Clinical Data of Natural Killer Cell Therapy in Metastatic Merkel Cell C...	NASDAQ:NK	NantKwest Inc
2019/11/06	06:08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NK	NantKwest Inc
2019/09/10	05:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NK	NantKwest Inc
2019/09/04	19:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:NK	NantKwest Inc
2019/08/24	05:10	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:NK	NantKwest Inc
2019/08/08	05:05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NK	NantKwest Inc
2019/08/08	05:02	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:NK	NantKwest Inc
2019/08/07	05:09	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NK	NantKwest Inc
2019/08/06	06:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NK	NantKwest Inc
2019/06/24	21:00	Business Wire	NantKwest Launches First-in-class, First-in-human Phase I Clinical Trial With a Targeted PD-L1 t-haNK Cell Therapy in Patient...	NASDAQ:NK	NantKwest Inc
2019/06/11	05:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NK	NantKwest Inc
2019/06/08	05:48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NK	NantKwest Inc
2019/06/08	05:45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NK	NantKwest Inc
2019/06/08	05:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NK	NantKwest Inc
2019/06/08	05:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NK	NantKwest Inc